MMP-2 and TIMP-2 Expression Correlates with Poor Prognosis in Cervical Carcinoma—A Clinicopathologic Study Using Immunohistochemistry and mRNA in Situ Hybridization
- 30 June 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 73 (3) , 372-382
- https://doi.org/10.1006/gyno.1999.5381
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Control of matrix metalloproteinase activity in cancerThe Journal of Pathology, 1997
- Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinomaBritish Journal of Cancer, 1996
- The 72-kDa Metalloproteinase Immunostaining in Cervical Carcinoma: Relationship with Lymph Nodal InvolvementGynecologic Oncology, 1996
- Analysis of Expression of Matrix Metalloproteinases-2 and −9 in Hypopharyngeal Squamous Cell Carcinoma by in Situ HybridizationAnnals of Otology, Rhinology & Laryngology, 1995
- Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopyVirchows Archiv, 1994
- Expression and activity of MMPS and their regulators in ovarian cancerInternational Journal of Cancer, 1994
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- Molecular aspects of tumor cell invasion and metastasisCancer, 1993
- The matrix‐degrading metalloproteinasesBioEssays, 1992